← Open Payments lookup

MEGAN PICHETTE: Open Payments

NPI 1497491435 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,699 in 99 payments from 39 companies in 2025. Trend: 2023 $3,498 · 2024 $3,538 · 2025 $2,699

Food & beverage: $2,600Long term medical supply or device loan: $100
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation18$450
AstraZeneca Pharmaceuticals LP7$364
Daiichi Sankyo Inc.6$158
Janssen Biotech, Inc.6$129
Astellas Pharma US Inc1$126
Merck Sharp & Dohme LLC4$110
Regeneron Healthcare Solutions, Inc.4$108
Eisai Inc.3$81
Celgene Corporation3$72
Aveo Pharmaceuticals, Inc.2$71

Products named: KISQALI, CALQUENCE, ENHERTU, IMFINZI, Fabhalta, Vyloy, KEYTRUDA, Lenvima.

Industry payments across CA — which companies pay providers there.